Kazutaka Terahara 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（19 件）

• [2026] A poorly reactogenic lipid nanoparticle-mRNA vaccine unveils an innate immune pathway for adverse reactions
  DOI: https://doi.org/10.1038/s41541-026-01441-9
• [2026] Prefusion-stabilized SARS-CoV-2 spike reshapes antigenic hierarchy and antibody targeting against conserved and occluded epitopes
  DOI: https://doi.org/10.1038/s41541-026-01464-2
• [2025] Antibody durability is influenced by interleukin-2 production by undifferentiated memory T helper cells and extensive B cell clonal expansion
  DOI: https://doi.org/10.1016/j.celrep.2025.115934
• [2024] Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest variants
  DOI: https://doi.org/10.1126/scitranslmed.adp9927
• [2023] XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections
  DOI: https://doi.org/10.1016/j.celrep.2023.112123
• [2023] CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes
  DOI: https://doi.org/10.1126/sciadv.adf0661
• [2023] Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain
  DOI: https://doi.org/10.1038/s41467-023-37128-1
• [2022] Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine
  DOI: https://doi.org/10.1016/j.xcrm.2022.100631
• [2022] Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag/Vif-specific CD8+ T cells but not CD4+ T cells
  DOI: https://doi.org/10.1016/j.ymthe.2022.02.023
• [2022] SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype
  DOI: https://doi.org/10.1016/j.isci.2022.104959

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。